Actively Recruiting
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
Led by Beijing Chao Yang Hospital · Updated on 2025-08-22
200
Participants Needed
10
Research Sites
208 weeks
Total Duration
On this page
Sponsors
B
Beijing Chao Yang Hospital
Lead Sponsor
S
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Severe asthma is a complex and heterogeneous disease. Patients with severe asthma can present with different types of airway inflammation, and are often accompanied by a variety of comorbidities and risk factors. Identification of potentially modifiable factors affecting prognosis, that is, "treatable characteristics", and individualized bundle management based on these characteristics may help to improve the quality of life of patients with asthma and improve the level of asthma control. Through joint research, this project aims to evaluate the treatable characteristics of asthma in patients with severe asthma in tertiary hospitals across the country, including lung function, fractional exhaled nitric oxide, blood routine, allergen IgE, chest CT, and a detailed questionnaire. The distribution of treatable characteristics of patients with severe asthma and its impact on the quality of life or asthma control level of patients were investigated. For patients with severe asthma, multidisciplinary consultation and shared decision-making were used to establish an individualized bundle management model based on the treatable characteristics of severe asthma. A 6-month randomized parallel controlled clinical trial was conducted to determine whether this model was superior to conventional management in improving the quality of life or asthma control in patients with severe asthma. The implementation of this project will build a new model of individualized management of severe asthma based on treatable characteristics and improve the management level of severe asthma
CONDITIONS
Official Title
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older and under 80 years with a definite asthma diagnosis for at least 6 months
- Meet 2024 GINA criteria for severe asthma defined as uncontrolled asthma despite high-dose ICS plus LABAs or worsening symptoms after tapering
- Willing to accept multidisciplinary evaluation and sign informed consent
- Able to participate in the study and 6-month follow-up per protocol
You will not qualify if you...
- Having other severe lung diseases like severe bronchiectasis or pulmonary tuberculosis
- Chest or abdominal surgery within the past 3 months
- Eye surgery within the past 3 months
- Myocardial infarction within the past 3 months
- Currently receiving anti-tuberculosis treatment
- Pregnant or breastfeeding women
- Use of macrolides or anti-IgE, anti-IL-5, or anti-IL-5R treatments within 4 weeks before screening
- Use of inhaled ICS+LABA+LAMA for 4 weeks before screening
- Allergy to macrolides
- QTc interval prolongation greater than 480ms
- Taking medications that interact with azithromycin causing QTc prolongation or existing ECG abnormalities that may cause arrhythmia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 10 locations
1
Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100020
Actively Recruiting
2
Beijing Tiantan Hospital Affiliated to Capital Medical University
Beijing, Beijing Municipality, China
Actively Recruiting
3
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
Actively Recruiting
4
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Actively Recruiting
5
Henan Provincial People's Hospital
Zhengzhou, Henan, China
Actively Recruiting
6
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
Actively Recruiting
7
The First Affiliated Hospital of China Medical University
Shenyang, Liaoning, China
Actively Recruiting
8
The First Affiliated Hospital of Guangzhou Medical University
Shanghai, Shanghai Municipality, China
Actively Recruiting
9
Shanxi Bethune Hospital
Taiyuan, Shanxi, China
Actively Recruiting
10
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Actively Recruiting
Research Team
K
Kewu Huang, professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here